ARTICLE | Clinical News
Bevirimat: Phase IIb data
November 3, 2008 8:00 AM UTC
An Australian Phase IIb (Study 204) trial in 32 patients with HIV showed that bevirimat met the primary endpoint of demonstrating bevirimat plasma levels to be well above 20 µg/mL, which is the previo...